Premium
A FIRST‐IN‐HUMAN TRIAL OF THE NOVEL MULTI‐ACTION THERAPY TINOSTAMUSTINE (EDO‐S101) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) HODGKIN LYMPHOMA (HL)
Author(s) -
Pinto A.,
De Filippi R.,
Zinzani P.,
Driessen C.,
Tun H.W.,
Hilgier K.,
Remmy D.,
Mehrling T.,
O'Connor O.A.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.137_2630
Subject(s) - medicine , neutropenia , refractory (planetary science) , nausea , toxicity , vomiting , gastroenterology , oncology , regimen , pharmacology , astrobiology , physics